Monday, March 15, 2010

Mannkind (MNKD)

Quick note:  Taking a shot at MNKD as FDA issued a Complete Response letter regarding the New Drug Application for AFREZZA Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.  


- Buy to open April $10 puts for $1.80.  


Good luck!